Skip to main content
. 2020 Sep 24;123(12):1749–1756. doi: 10.1038/s41416-020-01087-x

Fig. 1.

Fig. 1

Chart depicting CRISPR/Cas9-based LOF screening strategy to identify molecular targets synthetically lethal with sunitinib treatment.